LENZ THERAPEUTICS, INC. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- LENZ THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $395.00K, a 75.56% increase year-over-year.
- LENZ THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-06-30 was $225.00K.
- LENZ THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2023-06-30 was $157.00K, a 62.08% decline year-over-year.
- LENZ THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2022-06-30 was $414.00K.
- LENZ THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $873.00K.
- LENZ THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $157.00K, a 76.07% decline from fiscal 2022.
- LENZ THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $656.00K, a 114.38% increase from fiscal 2021.
- LENZ THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for fiscal 2021 was $306.00K.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $395.00K 10-Q · filed 2026-08-11 | |
| 2025-12-31 | $873.00K 10-K · filed 2026-03-24 | |
| 2025-06-30 | $225.00K 10-Q · filed 2026-08-11 | |
| 2023-12-31 | $157.00K 10-K · filed 2024-02-27 | |
| 2023-06-30 | $157.00K 10-Q · filed 2023-11-13 | |
| 2022-12-31 | $656.00K 10-K · filed 2024-02-27 | |
| 2022-06-30 | $414.00K 10-Q · filed 2023-11-13 | |
| 2021-12-31 | $306.00K 10-K · filed 2023-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |